Hepatitis B e-antigen Persistency is Associated with the Properties of HBV-Specific CD8 T Cells in CHB Patients

被引:28
|
作者
Peng, Guoping [1 ]
Luo, Benyan [2 ]
Li, Jie [1 ]
Zhao, Dongjiu [1 ]
Wu, Wei [1 ]
Chen, Feng [1 ]
Chen, Zhi [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Inst Infect Dis,Med Coll, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China
关键词
Hepatitis B e-antigen; HBV-specific T cellular response; viral load; histological grades; PD-1; REGULATORY T; VIRUS DNA; IMMUNE-RESPONSE; HBEAG; MUTATIONS; RISK; DYSFUNCTION; PREDICTORS; TOLERANCE; GENOTYPES;
D O I
10.1007/s10875-010-9483-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the correlation between the HBeAg and the properties of HBV-specific CD8 T cells, as well as liver injury, serum HBV markers, liver histology, the frequency and phenotypic characteristics of CD4(+)CD25(+) Treg and HBV-pentamer(+) CD8 T cells were measured. No significant differences between the median serum ALT levels, the frequency and Foxp3 expression of CD4(+)CD25(+) Treg, and liver fibrosis were observed. Higher HBV DNA levels in HBeAg+ patients were observed, while liver necroinflammation was more severe in HBeAg- patients. Differences in HBV-pentamer(+) T cell frequency were not significant, but increased PD-1 and CTLA-4 expression on HBV-specific CD8 T cells was seen in the HBeAg+ group. HBV-peptide stimulation with anti-PD-L1 and anti-CTLA-4 significantly increased the proliferation in PBMCs from both groups, but enhanced IFN-gamma production only in the HBeAg+ patients. Therefore, HBeAg persistency in CHB patients probably increased the expression of PD-1 and CTLA-4 on HBV-specific CD8 T cells, which may be associated with the low intensity of T cell responses and high HBV DNA load.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 50 条
  • [41] IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B
    Chua, Conan
    Salimzadeh, Loghman
    Ma, Ann T.
    Adeyi, Oyedele A.
    Seo, Hobin
    Boukhaled, Giselle M.
    Mehrotra, Aman
    Patel, Anjali
    Ferrando-Martinez, Sara
    Robbins, Scott H.
    La, Danie
    Wong, David
    Janssen, Harry L. A.
    Brooks, David G.
    Feld, Jordan J.
    Gehring, Adam J.
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (12)
  • [42] Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro
    Zhang, Heng-Hui
    Mei, Ming-Hui
    Fei, Ran
    Liao, Wei-Jia
    Wang, Xue-Yan
    Qin, Li-Ling
    Wang, Jiang-Hua
    Wei, Lai
    Chen, Hong-Song
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 36 (04) : 841 - 848
  • [43] EBNA1 antigen-specific CD8+T cells in cerebrospinal fluid of patients with multiple sclerosis
    Erdur, Hebun
    Scholz, Veronika
    Streitz, Mathias
    Hammer, Markus
    Meisel, Christian
    Schoenemann, Constanze
    Wandinger, Klaus-Peter
    Rosche, Berit
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 294 : 14 - 17
  • [44] Immunomodulation and RNA interference alter hepatitis B virus-specific CD8 T-cell recognition of infected HepG2-NTCP
    Kuipery, Adrian
    Vasquez, Juan Diego Sanchez
    Mehrotra, Aman
    Feld, Jordan J.
    Janssen, Harry L. A.
    Gehring, Adam J.
    HEPATOLOGY, 2022, 75 (06) : 1539 - 1550
  • [45] Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study
    Chang, Young
    Choe, Won Hyeok
    Sinn, Dong Hyun
    Lee, Jeong-Hoon
    Ahn, Sang Hoon
    Lee, Hyewon
    Shim, Jae-Jun
    Jun, Dae Won
    Park, Soo Young
    Nam, Joon Yeul
    Cho, Eun Ju
    Yu, Su Jong
    Lee, Dong Ho
    Lee, Jeong Min
    Kim, Yoon Jun
    Kwon, So Young
    Paik, Seung Woon
    Yoon, Jung-Hwan
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (11) : 1407 - 1414
  • [46] Circulating PD-1hiCXCR5+CD4+ T cells are associated with a decrease in hepatitis B surface antigen levels in patients with chronic hepatitis B who are receiving peginterferon-α therapy
    Zhang, Li
    Li, Hu
    Ren, Hong
    Hu, Peng
    MOLECULAR IMMUNOLOGY, 2018, 103 : 270 - 278
  • [47] Blockade of Tim-3 signaling restores the virus-specific CD8+ T-cell response in patients with chronic hepatitis B
    Wu, Wei
    Shi, Yu
    Li, Shuping
    Zhang, Yun
    Liu, Yanning
    Wu, Yihua
    Chen, Zhi
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (05) : 1180 - 1191
  • [48] Systemic Antigen Cross-Presented by Liver Sinusoidal Endothelial Cells Induces Liver-Specific CD8 T-Cell Retention and Tolerization
    von Oppen, Nanette
    Schurich, Anna
    Hegenbarth, Silke
    Stabenow, Dirk
    Tolba, Rene
    Weiskirchen, Ratf
    Geerts, Albert
    Kolanus, Waldemar
    Knolle, Percy
    Diehl, Linda
    HEPATOLOGY, 2009, 49 (05) : 1664 - 1672
  • [49] CD8 T cell-mediated depletion of HBV surface-antigen-expressing, bilineal-differentiated liver carcinoma cells generates highly aggressive escape variants
    Qiu, Na
    Srikanth, Akshaya
    Mulaw, Medhanie
    Tharehalli, Umesh
    Selvachandran, Shanthiya
    Wagner, Martin
    Seufferlein, Thomas
    Stifter, Katja
    Lechel, Andre
    Schirmbeck, Reinhold
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [50] Induction of broad multifunctional CD8+and CD4+T cells by hepatitis B virus antigen-based synthetic long peptides ex vivo
    Jansen, Diahann T. S. L.
    de Beijer, Monique T. A.
    Luijten, Robbie J.
    Kwappenberg, Kitty
    Wiekmeijer, Anna-Sophia
    Kessler, Amy L.
    Pieterman, Roel F. A.
    Bouzid, Rachid
    Krebber, Willem-Jan
    de Man, Robert A.
    Melief, Cornelis J. M.
    Buschow, Sonja I.
    FRONTIERS IN IMMUNOLOGY, 2023, 14